ADVFN Logo

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

NVAX Novavax Inc

5,56
-0,01 (-0,18%)
Nach Börsenschluss
Zuletzt aktualisiert: 00:05:29
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Novavax Inc NVAX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,01 -0,18% 5,56 00:05:29
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
5,62 5,52 5,77 5,565 5,57
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
05.12.202322:01PRNCANovavax's Updated COVID-19 Vaccine Now Authorized in Canada
05.12.202314:45EDGAR2Form 8-K - Current report
28.11.202319:13IHMARKETNEWSWall Street Radar: Amazon, Blackrock, General Motors, Eli..
28.11.202312:00PRNUSNovavax's Updated Protein-based COVID-19 Vaccine Now an..
17.11.202322:36EDGAR2Form 8-K - Current report
17.11.202313:15PRNUSNovavax Makes Changes to Executive Leadership Team to..
10.11.202315:25PRNUSNovavax to Participate in Jefferies London Healthcare..
09.11.202314:05EDGAR2Form 8-K - Current report
09.11.202314:00PRNUSNovavax Reports Third Quarter 2023 Financial Results and..
09.11.202313:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.11.202313:02IHMARKETNEWSThursday’s Wall Street Highlights: Nvidia, Duolingo, Disney,..
08.11.202312:59IHMARKETNEWSWednesday’s Wall Street Highlights: Spirit AeroSystems,..
07.11.202323:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.11.202322:00EDGAR2Form 8-K/A - Current report: [Amend]
02.11.202314:25PRNUSNovavax to Host Conference Call to Discuss Third Quarter..
31.10.202321:48PRNUSNovavax's Updated COVID-19 Vaccine Now Approved in the EU
31.10.202321:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.10.202321:37PRNUSNovavax's Updated COVID-19 Vaccine Now Approved in the EU
31.10.202318:08PRNUSNovavax's Updated Nuvaxovid™ COVID-19 Vaccine Receives..
31.10.202317:58PRNUSNovavax's Updated Nuvaxovid™ COVID-19 Vaccine Receives..
18.10.202314:05PRNUSNovavax Receives Full Marketing Authorization for Prototype..
18.10.202314:00PRNUSNovavax's Prototype COVID-19 Vaccine Nuvaxovid™ Receives..
13.10.202315:29PRNUSNovavax COVID-19 Vaccine Doses Available at Major Retail..
11.10.202314:00PRNUSNovavax Advances Science Supporting Protein-based Vaccine..
10.10.202315:06PRNUSNovavax Launches Choose to Protect™ Campaign to Educate..
05.10.202317:18PRNCALe vaccin 2023-2024 contre la COVID-19 de Novavax est..
04.10.202313:22IHMARKETNEWSWednesday’s Wall Street Highlights: Apple, Intel, Cal-Maine,..
03.10.202322:59EDGAR2Form 8-K - Current report
03.10.202322:14PRNUSNovavax 2023-2024 COVID-19 Vaccine Now Authorized and..
03.10.202321:50PRNUSNovavax 2023-2024 COVID-19 Vaccine Now Authorized and..
28.9.202319:26DJNCanada Approves Use of Pfizer and BioNTech Covid-19 Booster
19.9.202323:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.9.202318:05DJNCanada Approves Use of Moderna's Covid-19 Booster
11.9.202321:59DJNNovavax Stock Drops 13% on Pending FDA Authorization for..
08.9.202322:31PRNUSNovavax Announces Grant of Inducement Awards Pursuant to..
08.9.202318:00PRNUSNovavax to Participate in Upcoming September Conferences
22.8.202322:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.8.202313:00PRNUSNovavax's Updated Protein-based XBB COVID Vaccine Induced..
18.8.202322:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.8.202312:08EDGAR2Form SC 13G - Statement of acquisition of beneficial..
08.8.202322:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
08.8.202314:05EDGAR2Form 8-K - Current report
08.8.202314:00PRNUSNovavax Reports Second Quarter 2023 Financial Results and..
08.8.202313:56EDGAR2Form 8-K - Current report
08.8.202313:48EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08.8.202313:20EDGAR2Form 8-K - Current report
08.8.202312:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01.8.202315:25PRNUSNovavax to Host Conference Call to Discuss Second Quarter..
11.7.202323:12EDGAR2Form 8-K - Current report
11.7.202314:56IHMARKETNEWSTuesday’s Wall Street Highlights: Amazon, Better..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

Support: +44 (0) 203 8794 460 | support@advfn.de